RIGBY JONATHAN enters ONCOLYTICS BIOTECH INC with 42.73K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

RIGBY JONATHAN

Filed: 1/2/2026ACC: 0001493152-26-000128

InsiderRIGBY JONATHANCIK 1356227

→

IssuerONCOLYTICS BIOTECH INCCIK 1129928

Director

Since Jan 2026

42.73K

Baseline shares

100% direct

42.73K

Direct ownership

1 position

255K

Derivative underlying

5 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Shares

Direct

Shares owned42.73K

Total

42.73K direct42.73K

Security Title	Shares Owned	Ownership Type
Common Shares	42.73K	Direct
Total	42.73K	42.73K direct

Derivative Holdings5

Stock Option

Direct

Underlying security

Common Shares

Underlying shares

45K

Shares owned

N/A

Exercise price

1.84

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Shares

Underlying shares

30K

Shares owned

N/A

Exercise price

2.76

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Shares

Underlying shares

30K

Shares owned

N/A

Exercise price

1.13

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Shares

Underlying shares

30K

Shares owned

N/A

Exercise price

1.08

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Shares

Underlying shares

120K

Shares owned

N/A

Exercise price

1.08

Expiration

—

Exercise window

—

Total

Underlying

255K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option Direct	Common Shares	1.84	—	—	45K	N/A
Stock Option Direct	Common Shares	2.76	—	—	30K	N/A
Stock Option Direct	Common Shares	1.13	—	—	30K	N/A
Stock Option Direct	Common Shares	1.08	—	—	30K	N/A
Stock Option Direct	Common Shares	1.08	—	—	120K	N/A
Total					255K	0.00